Precision BioSciences宣布PBGene-HBV将在2025年AASLD肝脏会议上进行重要口头报告

美股速递
Oct 14, 2025

Precision BioSciences公司近日宣布,其PBGene-HBV项目将在2025年AASLD肝脏会议®上进行重要的临时口头报告。这一消息表明该公司在肝病治疗领域的研发工作取得了重要进展,足以获得这一权威医学会议的重点关注。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10